Cellular Pump Sabotages Cancer Drug Studies that use Glow Chemical

News   Jan 03, 2008

 
Cellular Pump Sabotages Cancer Drug Studies that use Glow Chemical
 
 
 
 

RELATED ARTICLES

Cell Recycling System Offers Therapeutic Entry Point for Rare Disease Treatment

News

Scientists have demonstrated how an investigational drug works against a rare, fatal genetic disease, Niemann-Pick type C1 (NPC1).

READ MORE

Study Indicates 75% of Human Genome is Non-functional

News

An evolutionary biologist at the University of Houston has published new calculations that indicate no more than 25 percent of the human genome is functional.

READ MORE

Bone Cancer Drug Targets Tumors, Spares Other Organs

News

A study led by The University of Texas MD Anderson Cancer Center found a drug known as bone metastasis-targeting peptidomimetic (BMTP-11) has potential as a new therapeutic strategy for this devastating illness.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE